Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Contraception at 40].

G André1

  • 1andregab@noos.fr

Gynecologie, Obstetrique & Fertilite
|August 30, 2002
PubMed
Summary
This summary is machine-generated.

Contraception is essential for women in their 40s due to continued pregnancy risk. Oral contraceptives offer benefits but carry cardiovascular risks, necessitating careful method selection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of postmenopausal women: Collège National des Gynécologues et Obstétriciens Français (CNGOF) and Groupe d'Etude sur la Ménopause et le Vieillissement (GEMVi) Clinical Practice Guidelines.

Maturitas·2022
Same author

[Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines (Short version)].

Gynecologie, obstetrique, fertilite & senologie·2021
Same author

[Menopause hormone therapy and cognition. Postmenopausal women management: CNGOF and GEMVi clinical practice guidelines].

Gynecologie, obstetrique, fertilite & senologie·2021
Same author

In utero seizures revealing dentato-olivary dysplasia caused by SCN2A mutation.

Neuropathology and applied neurobiology·2017
Same author

Increased β2-adrenergic vasorelaxation at the early phase of endotoxemic shock in rats.

Vascular pharmacology·2015
Same author

Large noncollinearity and spin reorientation in the novel Mn2RhSn Heusler magnet.

Physical review letters·2014
Same journal

[How I do… to see the sliding sign by transvaginal ultrasonography?]

Gynecologie, obstetrique & fertilite·2016
Same journal

[Cell-free fetal DNA screening tests for trisomy 21].

Gynecologie, obstetrique & fertilite·2016
Same journal

[Lucy's cancer(s): A prehistorical origin?]

Gynecologie, obstetrique & fertilite·2016
Same journal

[Male age in assisted reproductive technologies: Is there a limit?]

Gynecologie, obstetrique & fertilite·2016
Same journal

[Iodinated contrast in pregnant women and neonatal thyroid function].

Gynecologie, obstetrique & fertilite·2016
Same journal

[Breast cancer and diabetes mellitus: Complex interactions].

Gynecologie, obstetrique & fertilite·2016
See all related articles

Area of Science:

  • Reproductive Health
  • Gynecology
  • Pharmacology

Context:

  • Fertility declines in women aged 40, yet spontaneous pregnancy remains possible, highlighting the need for effective contraception.
  • Various contraceptive options exist, including local methods, intrauterine devices, and hormonal therapies.

Purpose:

  • To review contraceptive options for women in their 40s, emphasizing benefits and risks.
  • To guide clinical decision-making regarding contraception for this demographic.

Summary:

  • Progestogen-only pills are generally not recommended due to potential hyperestrogenic adverse events.
  • Progestin implants are suitable for women with estrogen contraindications or compliance issues with oral contraceptives.
  • Oral contraceptives provide benefits like cycle control and reduced risk of gynecological cancers but increase cardiovascular risks (thromboembolism).

Related Experiment Videos

Impact:

  • Informs healthcare providers about the nuanced risks and benefits of different contraceptive methods for women in their 40s.
  • Emphasizes the importance of respecting contraindications for oral contraceptives.
  • Highlights the need for careful consideration of progestin-based options when oral contraceptives are contraindicated.